Speaker illustration

Professor Marija Vavlukis

University Clinic for Cardiology, Skopje (North Macedonia)

Member of:

European Society of Cardiology
Heart Failure Association

Prof. d-r Marija Vavlukis has completed her Ph.D. at the age of 44 years from Ss’ Cyril and Methodius University in Skopje, Medical Faculty, Macedonia. She is a Head of ICCU at the University Clinic of Cardiology, with areas of interest: acute cardiac care conditions, acute and chronic CAD, non-invasive cardiac imaging, and preventive medicine. She is a National Coordinator of The American-Austrian Foundation-Open Medical institute, National coordinator in ACVC for Macedonia, FESC since 2016. She is a nucleus member of the Working Group for coronary pathophysiology and microcirculation (2018-2022). She has published more than 60 papers in reputed journals, participated at national/international congresses, symposiums, workshops, other meetings with plenary or oral presentations on more than 40 occasions, and authored or co-authored more than 150 publications. She has been serving as an editorial board member and reviewer in several Journals of repute.

MPI SPECT CT-added value of hybrid systems in the diagnostic accuracy of MPI SPECT

Event: ICNC 2019

Topic: Hybrid and Fusion Imaging

Session: Clinical Case Poster session III

Thumbnail

Association of biomarkers of oxidative stress, stress glycaemia and glycated haemoglobin with coronary artery disease

Event: Acute Cardiovascular Care 2019

Topic: Biomarkers

Session: Acute Coronary Syndromes - Pathophysiology and Mechanisms, Biomarkers , Treatment, Revascularization Poster Discussant

Thumbnail

Predictors of mid-term clinical outcome of patients treated for acute coronary syndrome

Event: HEART FAILURE 2016

Topic: Metabolism / Ischemia / Reperfusion / Preconditioning

Session: Ischemia / Reperfusion / Preconditioning / Postconditioning

Thumbnail

Haemoglobin - a simple biochemical variable in prediction of in-hospital mortality in heart failure patients

Event: HEART FAILURE 2016

Topic: Prognosis (using biomarkers)

Session: Biomarkers

Thumbnail

This platform is supported by

logo Novo Nordisk